Drug Sales Trends for ESTRIOL/ESTRADIOL (50:50)-LETCO 0.25MG/


Annual Sales Revenues and Units Sold for ESTRIOL/ESTRADIOL (50:50)-LETCO 0.25MG/
| Drug Name | Revenues (USD) | Units | Year |
|---|---|---|---|
| ESTRIOL/ESTRADIOL (50:50)-LETCO 0.25MG/ | ⤷ Start Trial | ⤷ Start Trial | 2022 |
| ESTRIOL/ESTRADIOL (50:50)-LETCO 0.25MG/ | ⤷ Start Trial | ⤷ Start Trial | 2021 |
| ESTRIOL/ESTRADIOL (50:50)-LETCO 0.25MG/ | ⤷ Start Trial | ⤷ Start Trial | 2020 |
| ESTRIOL/ESTRADIOL (50:50)-LETCO 0.25MG/ | ⤷ Start Trial | ⤷ Start Trial | 2019 |
| ESTRIOL/ESTRADIOL (50:50)-LETCO 0.25MG/ | ⤷ Start Trial | ⤷ Start Trial | 2018 |
| ESTRIOL/ESTRADIOL (50:50)-LETCO 0.25MG/ | ⤷ Start Trial | ⤷ Start Trial | 2017 |
| >Drug Name | >Revenues (USD) | >Units | >Year |
